These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26875193)

  • 1. Is There a Role for Adjuvant Therapy in R0 Resected Gallbladder Cancer?: A Propensity Score-Matched Analysis.
    Go SI; Kim YS; Hwang IG; Kim EY; Oh SY; Ji JH; Song HN; Park SH; Park JO; Kang JH
    Cancer Res Treat; 2016 Oct; 48(4):1274-1285. PubMed ID: 26875193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic Experience.
    Gold DG; Miller RC; Haddock MG; Gunderson LL; Quevedo F; Donohue JH; Bhatia S; Nagorney DM
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):150-5. PubMed ID: 19297105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma.
    Kresl JJ; Schild SE; Henning GT; Gunderson LL; Donohue J; Pitot H; Haddock MG; Nagorney D
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):167-75. PubMed ID: 11777635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant Therapy in Resected Nonmetastatic Stage II-IV Gallbladder Cancer: A Generalized Propensity Score Analysis.
    Wan W; Zheng B; Sun W; Wang J; Shen S; Huang L; Liu H; Ni X; Liu H
    Oncol Res Treat; 2021; 44(7-8):390-399. PubMed ID: 34218220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Impact of Neoadjuvant Chemotherapy in Localized or Locoregionally Advanced Gallbladder Cancer: A Population-Based and Propensity Score Matched SEER Analysis.
    Xiong YC; Yang ZY; Gong A; Wu ZY; Liu SL; Zhu YD; Song XL; Chu BF; Wu XS; Gong W
    Cancer Control; 2024; 31():10732748241271682. PubMed ID: 39105433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04).
    Lee SU; Seong J; Kim TH; Im JH; Kim WC; Kim K; Park HJ; Kim TG; Kim Y; Jeong BK; Kim JH; Kim BH; Nam TK
    Cancer Biol Med; 2021 Dec; 19(6):931-44. PubMed ID: 34919359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder Cancer.
    Ozer M; Goksu SY; Sanford NN; Porembka M; Khurshid H; Ahn C; Maxwell MC; Beg MS; Kazmi SM
    JAMA Netw Open; 2022 Feb; 5(2):e2146912. PubMed ID: 35171262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical Trial.
    Petrelli F; Labianca R; Zaniboni A; Lonardi S; Galli F; Rulli E; Rosati G; Corallo S; Ronzoni M; Cardellino GG; Mattioli R; Mambrini A; Ciuffreda L; Banzi M; Pusceddu V; Maiello E; Zampino M; Zagonel V; Marchetti P; Corsi D; Rimassa L; Cinieri S; Sobrero A
    JAMA Oncol; 2020 Apr; 6(4):547-551. PubMed ID: 32053133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy analysis of surgical combined with postoperative adjuvant therapy for T3 gallbladder carcinoma: a multicenter retrospective study].
    Yang FC; Hu J; Su TH; Geng ZM; Zhang K; Ding J; Lei ZQ; Yi B; Li JD; Tang ZH; Cheng ZJ; Qiu YH
    Zhonghua Wai Ke Za Zhi; 2023 Oct; 61(10):863-870. PubMed ID: 37653988
    [No Abstract]   [Full Text] [Related]  

  • 10. Gemcitabine-cisplatin (GC) as adjuvant chemotherapy in resected stage II and stage III gallbladder cancers (GBC): a potential way forward.
    Ostwal V; Swami R; Patkar S; Majumdar S; Goel M; Mehta S; Engineer R; Mandavkar S; Kumar S; Ramaswamy A
    Med Oncol; 2018 Mar; 35(4):57. PubMed ID: 29564657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival Outcomes of Gemcitabine Plus S-1 Adjuvant Chemotherapy after Surgical Resection for Advanced Biliary Tract Cancer.
    Hosoda K; Fukushima K; Shimizu A; Motoyama H; Kubota K; Notake T; Sugenoya S; Hayashi H; Yasukawa K; Kobayashi R; Soejima Y
    Oncology; 2021; 99(11):703-712. PubMed ID: 34515195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience.
    Wang J; Narang AK; Sugar EA; Luber B; Rosati LM; Hsu CC; Fuller CD; Pawlik TM; Miller RC; Czito BG; Tuli R; Crane CH; Ben-Josef E; Thomas CR; Herman JM
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S1100-6. PubMed ID: 26224402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant treatment for resected rectal cancer: impact of standard and intensified postoperative chemotherapy on disease-free survival in patients undergoing preoperative chemoradiation-a propensity score-matched analysis of an observational database.
    Garlipp B; Ptok H; Benedix F; Otto R; Popp F; Ridwelski K; Gastinger I; Benckert C; Lippert H; Bruns C
    Langenbecks Arch Surg; 2016 Dec; 401(8):1179-1190. PubMed ID: 27830368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of fluoropyrimidine-based adjuvant chemotherapy on biliary tract cancer after R0 resection.
    Kim YS; Jeong CY; Song HN; Kim TH; Kim HJ; Lee YJ; Hong SC
    Chin J Cancer; 2017 Jan; 36(1):9. PubMed ID: 28086990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant radiotherapy improves long-term survival after resection for gallbladder cancer A population-based cohort study.
    Kamarajah SK; Al-Rawashdeh W; White SA; Abu Hilal M; Salti GI; Dahdaleh FS
    Eur J Surg Oncol; 2022 Feb; 48(2):425-434. PubMed ID: 34518052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China.
    Zhang G; Zhang C; Sun N; Xue L; Yang Z; Fang L; Zhang Z; Luo Y; Gao S; Xue Q; Mu J; Gao Y; Tan F; He J
    J Cancer Res Clin Oncol; 2022 Apr; 148(4):943-954. PubMed ID: 34013382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects of oxaliplatin-based neoadjuvant chemotherapy and chemoradiotherapy in patients with locally advanced rectal cancer: a single-center, retrospective cohort study.
    Okuyama T; Sameshima S; Takeshita E; Yoshioka R; Yamagata Y; Ono Y; Tagaya N; Noie T; Oya M
    World J Surg Oncol; 2018 Jun; 16(1):105. PubMed ID: 29871650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.
    Ecker BL; McMillan MT; Datta J; Lee MK; Karakousis GC; Vollmer CM; Drebin JA; Fraker DL; Roses RE
    Cancer; 2017 May; 123(6):967-976. PubMed ID: 28263387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Adjuvant Chemotherapy in ypT0-2N0 Patients Treated with Preoperative Chemoradiation Therapy and Radical Resection for Rectal Cancer.
    Park IJ; Kim DY; Kim HC; Kim NK; Kim HR; Kang SB; Choi GS; Lee KY; Kim SH; Oh ST; Lim SB; Kim JC; Oh JH; Kim SY; Lee WY; Lee JB; Yu CS
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):540-7. PubMed ID: 26068489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.